Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More It’s often assumed that as the complexity of an AI system increases, it ...
A systematic review found that genomic classifier tests can influence risk assessments and treatment decisions among patients with localized prostate cancer but studies evaluating these tests vary ...
Evaluating molecular alteration profiles to distinguish intraductal carcinoma of the prostate. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does ...